AB0624 A Positive Rheumatoid Factor with Chronic Arthritis Protects Against Renal Involvement in Patients with Systemic Lupus Erythematosus

BackgroundPrevious observation has found that SLE patients with arthritis tended to have less renal involvement, and the presence of rheumatoid factor (RF) might protect against lupus nephritis (LN).ObjectivesThis study was performed to determine whether the presence of chronic arthritis (CA) protec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.1107-1108
Hauptverfasser: Louthrenoo, W., Areerug, M., Kasitanon, N., Wangkaew, S., Sukitawut, W., Puntana, S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundPrevious observation has found that SLE patients with arthritis tended to have less renal involvement, and the presence of rheumatoid factor (RF) might protect against lupus nephritis (LN).ObjectivesThis study was performed to determine whether the presence of chronic arthritis (CA) protects against renal involvement or has less degree of nephritis in SLE patients.MethodsThe medical records of SLE patients, who were followed-up at the Division of Rheumatology, Chiang Mai University, were reviewed. Patients with CA were classified as a “case”. Controls comprised SLE patients who were close to the case in hospital number, but had no chronic arthritis (NCA). The ratio of case to control was 1:2. SLE disease activity was determined by the modified SLE disease activity index-2000 (mSLEDAI-2K). The severity of SLE was ascertained by the sum of the Mexican SLEDAI score. Organ damage was detected by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR). Renal activity was determined by the SLICC Renal Activity/Response Exercise (SLICC/RARE).ResultsThere were 46 cases (45 females) and 92 controls (90 females) with a mean age of 44.35±14.09 years and 42.03±13.61 years, respectively, and mean disease duration of 9.44±7.47 years and 9.75±7.17 years, respectively. Twenty-eight patients in the CA group had chronic arthritis before SLE diagnosis was made with a mean duration of 2.06±2.34 years (median 1 year). There was no significant difference between the CA and NCA group in the mSLEDAI score (3.50±5.15 vs. 3.25±4.73), the cumulative MEX-SLEDAI score (9.52±5.55 vs. 11.24±5.14), and the SLICC/ACR score (1.15±1.15 vs. 0.90±1.24); but the number of ACR classification criteria was significantly higher in the CA group (5.46±1.52 vs. 4.78±1.11, p=0.009). The CA group, within the ACR classification criteria, had significantly more arthritis (100% vs. 47.82%, p
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2015-eular.2550